Ventas is a reit - healthcare facilities business based in the US. Ventas shares (VTR) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $68.64 – an increase of 1.05% over the previous week. Ventas employs 498 staff and has a trailing 12-month revenue of around $4.9 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $68.64 |
|---|---|
| 52-week range | $41.38 - $71.36 |
| 50-day moving average | $66.63 |
| 200-day moving average | $61.95 |
| Wall St. target price | $75.63 |
| PE ratio | 357.5263 |
| Dividend yield | $1.8 (2.83%) |
| Earnings per share (TTM) | $0.19 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $68.29 from 2025-04-22
| 1 week (2025-04-17) | 0.53% |
|---|---|
| 1 month (2025-03-24) | 0.12% |
| 3 months (2025-01-24) | 12.28% |
| 6 months (2024-10-24) | 3.53% |
| 1 year (2024-04-24) | 56.59% |
|---|---|
| 2 years (2023-04-24) | 60.69% |
| 3 years (2022-04-22) | 30.37% |
| 5 years (2020-04-24) | 195.82% |
Valuing Ventas stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ventas's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ventas's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 358x. In other words, Ventas shares trade at around 358x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Ventas's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8463. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ventas's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ventas's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.9 billion.
The EBITDA is a measure of a Ventas's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.9 billion |
|---|---|
| Operating margin TTM | 15.99% |
| Gross profit TTM | $2.1 billion |
| Return on assets TTM | 1.8% |
| Return on equity TTM | 0.84% |
| Profit margin | 1.66% |
| Book value | $24.64 |
| Market Capitalization | $29.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 9.15% of net profits
Recently Ventas has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Ventas shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Ventas's case, that would currently equate to about $1.8 per share.
While Ventas's payout ratio might seem low, this can signify that Ventas is investing more in its future growth.
Ventas's most recent dividend payout was on 16 April 2025. The latest dividend was paid out to all shareholders who bought their shares by 30 March 2025 (the "ex-dividend date").
Ventas's shares were split on a 8757:10000 basis on 17 August 2015 . So if you had owned 10000 shares the day before before the split, the next day you'd have owned 8757 shares. This wouldn't directly have changed the overall worth of your Ventas shares – just the quantity. However, indirectly, the new 14.2% higher share price could have impacted the market appetite for Ventas shares which in turn could have impacted Ventas's share price.
Over the last 12 months, Ventas's shares have ranged in value from as little as $41.375 up to $71.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ventas's is 1.041. This would suggest that Ventas's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,350 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its over 800 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. The Company aims to deliver outsized performance by leveraging its unmatched operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.
Steps to owning and managing PLD, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMT, with 24-hour and historical pricing before you buy.